• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies

Posted on: Tuesday, 14 August 2007, 15:15 CDT

NEW YORK, Aug. 14 /PRNewswire/ -- The drug delivery industry is estimated to reach a market size of $91 billion in the United States alone. Find out how new scientific technologies are driving investments, alliances, and clinical trials to bring novel drug delivery technologies to market. The New Directions for Drug Delivery: Emerging Modes, Novel Science and Profitable Deal Strategies conference, scheduled for October 29-30, 2007, in Las Vegas, will bring together innovators, investors, and scientific team leaders from pharmaceutical, biotechnology, specialty pharmaceutical, drug delivery, and medical device companies worldwide. Learn from trailblazers and distinguished researchers and industry leaders about developments in controlled release technologies, nanobiomedicine, siRNa, protein delivery platforms, liposome drug delivery, tumor targeting and other novel applications for oral/nasal/transdermal/injectable and other systemic drug absorption platforms.

Preliminary Speakers Includes: -- Erkki Ruoslahti, MD, PhD, Distinguished Professor, Burnham Institute for Medical Research (at UCSB) -- Allan S. Hoffman, Professor of Bioengineering, University of Washington, College of Engineering -- Khursheed Anwer, PhD, Vice President, Research, Expression Genetics -- Bill van Antwerp, Distinguished Scientist and Chief Technology Officer, Medtronic -- Gregory I. Frost, PhD, Vice President and Chief Scientific Officer, Halozyme Therapeutics -- Seth Feuerstein, President & CEO, Carigent Therapeutics -- Ravi Kiron, PhD.Chief Operating Officer, LifeTech Innovations -- Maggie Pax, Senior Director, Business Development, MicroCHIPS -- Michael Arenberg, Executive Director, Business Development, Durect -- Fernando Alvarez-Nunez, PhD, Principal Scientist, Small Molecule Pharmaceutics, Amgen -- Ashutosh Sharma, PhD, Executive Vice President, Vyteris -- William Edelman, Chief Executive Officer, TyRx Pharma, Inc. -- Eric Fossel, PhD, Founder & CEO, Strategic Science & Technologies LLC -- Bill Lambert, PhD, Senior Vice President, Pharmaceutical Development, Pacira Pharmaceuticals -- Aaron F. Barkoff, Partner, McDonnell Boehnen Hulbert & Berghoff LLP

For speaking opportunities, contact Don Buford, CEO, iiBIG, at 212-300- 2521 or info@iibig.com.

TECHNOLOGY SHOWCASE PANEL: If your company provides products or services to drug delivery executives and you would like to schedule a 10-15 minute presentation, showcasing opportunities are available. Contact: Kellie Swanstrom, VP, Business Development, iiBIG 973-571-0867 or kellies@iibig.com.

FOR CONFERENCE UPDATES: Please visit: http://www.iibig.com/P0704 Call: 212-300-2523 E-mail: info@iibig.com

International Institute for Business Information & Growth LLC

CONTACT: Don Buford, Chief Executive Officer of International Institutefor Business Information & Growth LLC (iiBIG), +1-212-300-2521,info@iibig.com

Web site: http://www.iibig.com/http://www.iibig.com/P0704

Source: PRNewswire

More News in this Category